Geneva, June 4 -- International Clinical Trials Registry received information related to the study (TCTR20250521004) titled 'High-dose adenosine as a first-line regimen for stress cardiac magnetic resonance: a multicenter randomized controlled trial' on May 21.
Study Type: Interventional
Study Design:
Randomized
Primary Sponsor: Thai Red Cross Society
Condition:
Suspected or known coronary artery disease
adenosine response
high dose
standard dose
stress cardiac magnetic resonance
perfusion study, ischemic heart disease
adenosine response
high dose
standard dose
stress cardiac magnetic resonance
perfusion study, ischemic heart disease
Intervention:
High-dose adenosine stress regimen with a dose of 210 mcg/kg/min intravenously for...